Hans Edgar Bishop Lyell Immunopharma, Inc. (LYEL) insider trading activity

Hans Edgar Bishop is of Lyell Immunopharma, Inc.. Currently has a direct ownership of 4.69 Million shares of LYEL, which is worth approximately $7.68 Million. The most recent transaction as insider was on Sep 08, 2022, when has been sold 145,380 shares (Common Stock) at a price of $0.1 per share, resulting in proceeds of $14,538. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 4.69M

0% 3M change

0% 12M change

Total Value Held $7.68 Million

Hans Edgar Bishop Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Sep 08 2022	BUY Exercise of conversion of derivative security	$14,538 $0.1 p/Share	145,380 Added 3.01%	4,685,614 Common Stock
Feb 23 2022	BUY Exercise of conversion of derivative security	$99,343 $0.1 p/Share	993,428 Added 17.95%	4,540,234 Common Stock
Jun 21 2021	BUY Conversion of derivative security	-	546,806 Added 13.36%	3,546,806 Common Stock

Also insider at

SANA

Sana Biotechnology, Inc. Healthcare

AGILENT TECHNOLOGIES, INC. Healthcare

Director

HEB